Press release
Netherton Syndrome Market is expected to reach US$ 74.31 million by 2027: Lifemax Laboratories, Azitra, Sixera Pharma Ab, Dermelix Biotherapeutics, Matrisys Bioscience, Quoin Pharmaceuticals Ltd
The Insight Partners market research study of "Netherton Syndrome Market to 2027 – Global Analysis and Forecast by Therapy and Region,". The report highlights trends prevailing in the global Netherton syndrome market, and the drivers and hindrances pertaining to the market growth.Major Industry Key Players Include Lifemax Laboratories, Inc.; Azitra, Inc.; Sixera Pharma Ab; Dermelix Biotherapeutics; Matrisys Bioscience; Quoin Pharmaceuticals Ltd.; and Krystal Biotech, Inc. are a few of the leading companies operating in the Netherton syndrome market.
Request a sample Report of Netherton Syndrome Market at: https://www.theinsightpartners.com/sample/TIPRE00013771/?utm_source=openpr%2F10291
Netherton syndrome is a rare disorder characterized by trichorrhexis invaginata, atopic diathesis, and ichthyosiform erythroderma. The trichorrhexis invaginata indicates short and brittle hair, atopic diathesis represents susceptibility to allergy problems while ichthyosiform erythroderma encompasses red, inflamed, scaly skin.
Netherton syndrome is hereditary as it is an autosomal recessive trait. The disease is majorly caused due to mutations associated with SPINK5 gene. In some cases, although there is no family history of the disease, the syndrome is revealed even when two healthy parents that carry the mutated recessive gene have a child, which receives both copies of the recessive gene.
Based on therapy, the global Netherton syndrome market is segmented into keratolytic agents, oral and topical steroids and retinoids, topical calcineurin inhibitors, biological therapies, and radiation therapies. In 2019, the keratolytic agents segment held the largest share of the global Netherton syndrome market. However, the biological therapy segment is estimated to register the highest CAGR in the market during the forecast period. The growth of the market for the biological therapy segment is attributed to the increasing adoption of biological therapy due to its beneficial treatment outcomes.
Foundation for Ichthyosis& Related Skin Types (FIRST) in collaboration with National Health Council (NHC) developed an organization that aims to improve lives and seek cures for the patients affected by ichthyosis and related skin types. The organization provides accurate and timely information regarding Netherton syndrome and ichthyosis that helps the patients to meet social, medical and educational needs of the disease community. Furthermore, the Ichthyosis Support Group (ISG) aims to protect and preserve the health and relieves patients affected by ichthyosis and other associated condition. The ISG provides information pack, distributes bulletins and newsletters organize children’s residential camps and others.
Based on therapy, the global Netherton syndrome market is segmented into keratolytic agents, oral and topical steroids and retinoids, topical calcineurin inhibitors, biological therapies, and radiation therapies. In 2019, the keratolytic agents segment held the largest share of the market. Growth of this segmental market is attributed to the increasing product launches and robust existing product pipeline. In addition, strategic activities by service providers such as collaborations, mergers and acquisitions, and expansions to expedite drug timeline are further accelerating the growth of the market. However, the biological therapy segment is projected to register the highest CAGR in the global Netherton syndrome market during 2020–2027.
Product launches and research collaborations are the commonly adopted strategies by companies to expand their footprint worldwide and meet the growing consumer demand. The Netherton syndrome market players adopted the strategy of product innovations to cater to changing customer demand across the world, which also permits them to maintain their brand name globally.
To read more about the report, visit @ https://www.theinsightpartners.com/sample/TIPRE00013771/?utm_source=openpr%2F10291
Contact US:
If you have any queries about this report or would like further information, please contact us:
North America: +1 646 491 9876
Asia-Pacific: +91 20 6727 8686
Email: sales@theinsightpartners.com
ABOUT US:
The Insight Partners is a one stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Netherton Syndrome Market is expected to reach US$ 74.31 million by 2027: Lifemax Laboratories, Azitra, Sixera Pharma Ab, Dermelix Biotherapeutics, Matrisys Bioscience, Quoin Pharmaceuticals Ltd here
News-ID: 2187452 • Views: …
More Releases from The Insight Partners
Insect Pest Control - Obtain PDF Sample Copy
The Insect Pest Control Market size is projected to reach US$ 14.85 billion by 2031 from US$ 21.33 billion in 2024. The market is expected to register a CAGR of 5.4% during 2025-2031. The proactive health measures, combined with heightened consumer awareness about disease prevention, have boosted the demand for both professional pest control services and DIY products. The convergence of public health policies, regulatory vigilance, and increased risk perception…
Denim Fabrics - Obtain PDF Sample Copy
The denim fabrics market size is projected to reach US$ 28.69 billion by 2031 from US$ 22.32 billion in 2024. The market is expected to register a CAGR of 3.8% during 2025-2031. The denim fabrics market is growing steadily owing to changing consumer preferences, fashion trends, and increasing accessibility. Denim has evolved from being a utilitarian fabric to a mainstream fashion item, appreciated for its flexibility, comfort, and ease. With…
Photomedicine Devices and Technologies Market Global Rising Demand & Huge Scope …
A new market study report by The Insight Partners on the Photomedicine Devices and Technologies Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period.
Get PDF Sample…
Genetic Testing Services Market Global Rising Demand & Huge Scope Till 2031
Genetic Testing Services Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market…
More Releases for Netherton
Netherton Syndrome Market is expected to reach USD 2.5 billion by 2034
Netherton Syndrome is a rare, inherited autosomal recessive skin disorder caused by mutations in the SPINK5 gene, which encodes the serine protease inhibitor LEKTI. The condition is characterized by ichthyosiform erythroderma, hair shaft abnormalities (trichorrhexis invaginata), and immune system dysfunction, often leading to recurrent infections and severe allergic manifestations. The prevalence is estimated at 1 in 200,000 births worldwide, making it a challenging orphan disease to diagnose and treat.
Download Full…
Evolving Market Trends In The Netherton Syndrome Industry: Advancements In Serin …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Is the Expected Netherton Syndrome Market Size During the Forecast Period?
The market size of the Netherton syndrome has experienced significant growth over the recent years. It is projected to escalate from $1.15 billion in 2024 to $1.27 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.2%. The notable growth…
Netherton Syndrome Pipeline, Therapeutics Assessment, Clinical Trials, Drugs, an …
DelveInsight's, "Netherton Syndrome Pipeline Insight 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Netherton Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Netherton Syndrome Research. Learn more about…
Netherton Syndrome Clinical Trials, Pipeline Insights, Treatment Drugs, and Comp …
DelveInsight's, "Netherton Syndrome- Pipeline Insight, 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Netherton Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Netherton Syndrome Research. Learn more about…
Netherton Syndrome Pipeline Drugs, FDA Approvals, and Companies 2024
DelveInsight's, "Netherton Syndrome- Pipeline Insight, 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Netherton Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Netherton Syndrome Research. Learn more about…
Netherton Syndrome Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MO …
DelveInsight's, "Netherton Syndrome- Pipeline Insight, 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Netherton Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Netherton Syndrome Research. Learn more about…
